Vol.

No.

April 03, 2015Apr 03, 2015

Free

DOWNLOAD THE PDF

Cover Story

Over 48 Hours, Power Shifts at NCI, ACS, Dana-Farber and MD Anderson

By Paul Goldberg

Over the first two days in April, massive leadership changes occurred at top institutions in cancer research:

Resolving Disputes in Precision Medicine: The Question of CYP2D6 Remains Open

By Paul Goldberg

A Biomarker Court? Who Should Decide?

Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

In Brief

Cantley, Adams-Campbell to Deliver Lectures At AACR Annual Meeting in Philadelphia

Lucille Adams-Campbell to Deliver Minorities in Cancer Research Lecture at AACR Annual Meeting

Robert Gentleman appointed vice president of computational biology at 23andMe Inc.

Aleksandar Zafirovski named associate director for administration for Lurie Cancer Center at Northwestern University

Scripps Clinic Medical Group acquires three radiation oncology services

Aeterna Zentaris to transfer library of 100,000 compounds to center at Medical University of South Carolina

GlaxoSmithKline to establish third global center for vaccine research in Rockville, Md.

Drugs & Targets

FDA Approves Chelator Jadenu, an Oral Formulation of Exjade

FDA grants priority review to Kyprolis

FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer

MD Anderson Cancer Center and Astellas Pharma Inc. sign option agreement for AML research

Eli Lilly and OncoMed Pharmaceuticals to evaluate combination of demcizumab and Alimta

Merck and Syndax Pharmaceuticals to evaluate combination of Keytruda and entinostat

Intrexon Corporation and Merck Serono to collaborate on CAR-T cancer therapies

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 46 - December 13, 2024

Over 48 Hours, Power Shifts at NCI, ACS, Dana-Farber and MD Anderson

Resolving Disputes in Precision Medicine: The Question of CYP2D6 Remains Open

A Biomarker Court? Who Should Decide?

Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

In Brief

Cantley, Adams-Campbell to Deliver Lectures At AACR Annual Meeting in Philadelphia

Lucille Adams-Campbell to Deliver Minorities in Cancer Research Lecture at AACR Annual Meeting

Robert Gentleman appointed vice president of computational biology at 23andMe Inc.

Aleksandar Zafirovski named associate director for administration for Lurie Cancer Center at Northwestern University

Scripps Clinic Medical Group acquires three radiation oncology services

Aeterna Zentaris to transfer library of 100,000 compounds to center at Medical University of South Carolina

GlaxoSmithKline to establish third global center for vaccine research in Rockville, Md.

Drugs & Targets

FDA Approves Chelator Jadenu, an Oral Formulation of Exjade

FDA grants priority review to Kyprolis

FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer

MD Anderson Cancer Center and Astellas Pharma Inc. sign option agreement for AML research

Eli Lilly and OncoMed Pharmaceuticals to evaluate combination of demcizumab and Alimta

Merck and Syndax Pharmaceuticals to evaluate combination of Keytruda and entinostat

Intrexon Corporation and Merck Serono to collaborate on CAR-T cancer therapies

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login